Valsartan + Hydrochlorothiazide
Co-Valid is indicated for the
treatment of hypertension, to lower blood pressure:
- In patients
not adequately controlled with monotherapy.
- As initial
therapy in patients likely to need multiple drugs to achieve
their blood pressure goals.
Co-Valid is the combination tablet of valsartan,
an angiotensin II receptor blocker (ARB) and hydrochlorothiazide
(HCTZ), a diuretic.
- Tablets (valsartan/HCTZ
mg): 80/12.5, 160/12.5 and 160/25
Tablets (valsartan/HCTZ mg):
- 80/12.5 (2x14’s)
- 160/12.5 (1x14’s)
- 160/25 (1x14’s)